"Extraordinary Messiness"

Hollywood has taken up orphan diseases before--remember "Lorenzo's Oil"? And bioethics movies generally have been increasingly common, even just in the last year. Think "My Sister's Keeper". So why all the fuss about "Extraordinary Measures"?

Extraordinary-Measures.jpgBut maybe its the star power, maybe it's actually that it's a decent movie (although very few have said so except New York Magazine), but Extraordinary Measures is getting a great deal of attention as the father-turned-biotech startup investor-turned underdog against the pharmaceutical industry story has hit the big screen.

The only part that is of interest to me about this movie is that it has put a bright light on the path to drug development--and that it is anything but smooth and fraught with politics, financial calculations, and very little to do, ultimately, with saving the most vulnerable and sick among us.

For those of us in bioethics, you are probably saying "Um, yeah, tell me something I don't know," but for the general public who often rarely think about where their medications come from any further beyond the pharmacists counter, I would hope this film would be an enlightening view into the (sometimes dark) underbelly of R&D.

Moreover, the notion that even in this day and age, with all of our medical technology and the trillions we spend on healthcare each year, that there are (even very small) populations of children or adults whose conditions are "orphans" because developing treatments for them will not have significant enough return on investment, I'm guessing, would be as shocking to many Americans as it was to John Crowley when he learned that his children had the obscure "Pompe disease".

Ultimately, this movie is likely to join the ranks of other bioethics and pharma movies for the purposes of teaching and discussion, but one hopes that it will be remembered for offering a unique perspective on the extraordinary complications and messiness in pharmaceutical research and development involving orphan diseases.

Summer Johnson, PhD

contribute a comment

Your contributions to the conversation are very much appreciated. We do have a few simple guidelines, though. Be civil. Stay on topic. We reserve the right to remove comments that violate the aforementioned guidelines. One more thing: comments are moderated, so it may take a little while for your comment to be posted. Thanks.

what is this?

A 'Nature Top 50' science blog by the editors, staff and friends of The American Journal of Bioethics. Science writes: "To follow the latest twists in ... science stories with social impact, dive into this Web log"

The original story behind this blog

What people are saying about blog.bioethics.net

recently on blog.bioethics.net

March Issue of AJOB is Now Online!

Trans fat bans, peer recruitment for human subjects research, and the clash of culture versus the rights of physicians are the featured issues in this... (more)

Trans Fats Today. Hot Dogs Tomorrow?

Will banning artificial trans fats today effect your ability to have a hot dog tomorrow? On the The Bioethics Channel, Lorell LaBoube seeks an answer... (more)

Looking for Dr. Right? Get Yours via Speed Date!

Want to find your "Dr. Right"? Now, you can! You can meet your next doctor on a "speed date." Dne Texas hospital is trying its... (more)

End of Life-ology

William King is dying from MS. His two twenty-something sons, Ennis and Malcolm, already lost their mother to cancer 15 years earlier and now must... (more)

If You Are STILL Wondering Why Health Care Reform Is Important...

Check out this statistic from the Chicago Tribune today: "Illinois consumers to pay up to 60% more [for health insurance premiums], data show." When do... (more)

this blog's feed

  • Subscribe
    • XML
    • Google Reader or Homepage
    • Add to My Yahoo!
    • Subscribe with Bloglines
    • Subscribe in NewsGator Online
    • Add to My AOL
    • Convert RSS to PDF
    • Add to Technorati Favorites!
    • Add to your phone
    • Get RSS Buttons

info

archives

tags